The dermatology
drugs market includes medications that are used for the treatment of skin
conditions such as dermatitis (including eczema), rosacea, hyperhidrosis,
androgenic alopecia, onychomycosis, hair loss, acne, immune disorders
(including psoriasis), microbial infections (bacterial, fungal, and viral),
vascular and pigmented lesion removal, common warts, seborrheic keratosis, and
other skin diseases The market numbers within this briefing are restricted to
pharmaceutical (drug) treatments and do not cover biologic treatments for these
conditions which are included in a separate briefing.
Dermatology drugs
used to treat acne include local anesthetics, cleansers, anti-inflammatory
agents, anti-infectives, emollients, and astringents. These drugs are available
for both topical (external) use and internal use. These drugs can be sold as over-the-counter
(OTC) as well as prescription drugs. Major OTC dermatological drugs include
Differin, Lamisil, Monistat, and Abreva. Some of the major dermatology
prescription drugs include Clobetasol propionate, Flucinonidei, Baxdela, Siliq,
and Rhofade.
Read more at:
The global dermatology drugs market has been growing in the past years
with a CAGR of almost 5%. The year 2017 recorded growth in this market with a
net market value more than 18% higher than that of 2013, as per TBRC’s in-house
consultants.
TBRC’s latest report show the historic and future trends in the market
for each year with sourced reasons to support the growth claims.
The report also shows
the global dermatology drugs market to grow at a higher CAGR by 2021 as
compared to 2017, along with geographies best suited for investments with highest
return rate.
Sample report at:
Drug manufacturing companies are using genome testing to reduce the
time and costs spent in clinical trials. A clinical trial is a complex process
and it often takes months for a drug to be available in the market. This
deprives patients of cost-effective treatment. Researchers in the Rockefeller
University used genomic testing and data analytics to predict the response of
psoriasis patients for a given treatment. Genomic testing algorithms collect
gene-expression data from skin biopsies and detect activity in 50,000 different
genes. This technique can predict the response of a patient with an accuracy of
95% and within 12 weeks, thus saving significant time for clinical trials and
the launch of new drugs.
Request for discount:
https://www.thebusinessresearchcompany.com/sample.aspx?id=272&type=discount
Companies included in the report are Adobe Systems, Autodesk, Dassault
Systemes, Hexagon, and Synopsys.
About The Business Research
Company:
The Business Research Company is a Business Intelligence Company which
excels in company, market and consumer research. It has offices in the UK, the
US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business
Research Company
Europe: +44 207
1930 708
Asia: +91
8897263534
Americas: +1 315
623 0293
Email:
info@tbrc.info
